Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Annals of Thoracic Surgery|September 1, 1996
Colon perforation after lung transplantationT M Beaver, D A Fullerton, M R Zamora, et al.
Transplantation Proceedings|October 1, 1994
Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipientsM R Zamora, D A Fullerton, D N Campbell, et al.
Thorax|August 2, 2005
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenolO Sitbon, V V McLaughlin, D B Badesch, et al.
The American Journal of Physiology|October 1, 1991
Cellular adaptation during chronic neonatal hypoxic pulmonary hypertensionK R Stenmark, A A Aldashev, E C Orton, et al.
Lancet (London, England)|October 13, 2001
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled studyR N Channick, G Simonneau, O Sitbon, et al.
The European Respiratory Journal|October 1, 2003
Primary pulmonary hypertension, Castleman's disease and human herpesvirus-8T M Bull, C D Cool, A E Serls, et al.
Cardiology|January 1, 1995
Importance of angiotensin-converting enzyme in pulmonary hypertensionW T Abraham, M V Raynolds, B Gottschall, et al.
The Journal of Clinical Investigation|December 31, 1997
Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardiumB D Lowes, W Minobe, W T Abraham, et al.
The New England Journal of Medicine|February 1, 1996
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertensionR J Barst, L J Rubin, W A Long, et al.
Circulation|March 18, 1997
Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study GroupA L Hinderliter, P W Willis, R J Barst, et al.
Pageof 4